SCHEMBL13200028

SCHEMBL13200028

CC(C)(C)c1cc(CC(=O)Nc2ccc(NC(=O)c3cc(Cl)cc(Cl)c3)cc2)no1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 11/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 1/20 0.45
MAPK1 P28482 1/20 0.45
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
CSF1R P07333 2/20 0.43
EGFR P00533 1/20 0.43
RAF1 P04049 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13200022 0.91 FLT3 (0.56) FLT3SMN1; SMN2ALDH1A1MAPK1KDM4E
SCHEMBL13199938 0.88 FLT3 (0.55) FLT3SMN1; SMN2ALDH1A1MAPK1MEN1
SCHEMBL13200599 0.85 FLT3 (0.57) FLT3SMN1; SMN2ALDH1A1MEN1NPC1
SCHEMBL13200027 0.83 FLT3 (0.53) FLT3SMN1; SMN2MEN1NPC1RAB9A
SCHEMBL13199940 0.82 FLT3 (0.65) FLT3MEN1NPC1RAB9AKMT2A
SCHEMBL13200085 0.82 FLT3 (0.51) FLT3SMN1; SMN2CSF1RRAF1
SCHEMBL13200035 0.82 FLT3 (0.69) FLT3SMN1; SMN2KDM4EMEN1NPC1
SCHEMBL13234699 0.81 FLT3 (0.74) FLT3MEN1NPC1RAB9AKMT2A
SCHEMBL13200134 0.80 FLT3 (0.49) FLT3SMN1; SMN2MEN1NPC1RAB9A
SCHEMBL13200157 0.79 FLT3 (0.51) FLT3MAPK1CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7767670-B2 Substituted 3-carboxamido isoxazoles as kinase modulators AMBIT BIOSCIENCES CORPORATION (US) 2010-08-03 US disclosed
US-7767670-B2 Substituted 3-carboxamido isoxazoles as kinase modulators AMBIT BIOSCIENCES CORPORATION (US) 2010-08-03 US disclosed